Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Prss39 Activators

The chemical class known as PRSS39 Activators comprises a spectrum of compounds that can escalate the activity of PRSS39, a member of the serine protease family. These activators operate by engaging in various biochemical interactions that lead to the upregulation of PRSS39 activity, albeit through indirect pathways. Some activators within this class influence the cellular balance between proteases and their natural inhibitors, which can result in the upregulation of PRSS39 activity as a compensatory cellular response. This can occur through the inhibition of other proteases, thereby shifting the equilibrium and necessitating increased PRSS39 activity. Alternatively, molecules that modulate signaling pathways associated with the synthesis or regulation of proteases can also lead to an increase in PRSS39 activity. This modulation can prompt cellular mechanisms to enhance the expression or activity of PRSS39 to maintain homeostasis.

Within this class, activators can also affect the intracellular milieu in such a way that fosters an environment conducive to PRSS39 activation. For example, alterations in cellular ion concentrations or the inhibition of specific phosphatases can initiate a cascade of events that culminates in the activation of PRSS39. Enzymatic feedback loops are another target of PRSS39 Activators, wherein the inhibition of certain proteases triggers a response that results in the increased activity of PRSS39. Additionally, the alteration of protease zymogens into their active form can be a consequence of the action of PRSS39 Activators, further illustrating the diverse mechanisms through which these compounds can elevate the activity of PRSS39. This illustrates the multifaceted approach these activators take in modulating the activity of PRSS39, leveraging the intricate web of cellular processes that govern protease activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

AEBSF hydrochloride

30827-99-7sc-202041
sc-202041A
sc-202041B
sc-202041C
sc-202041D
sc-202041E
50 mg
100 mg
5 g
10 g
25 g
100 g
$65.00
$122.00
$428.00
$851.00
$1873.00
$4994.00
33
(1)

An irreversible serine protease inhibitor that may upregulate PRSS39 expression as a compensatory response due to inhibition of related proteases.

Gabexate mesylate

56974-61-9sc-215066
5 mg
$100.00
(0)

A serine protease inhibitor; might enhance PRSS39 levels by triggering protease inhibitor responses.

Nafamostat mesylate

82956-11-4sc-201307
sc-201307A
10 mg
50 mg
$82.00
$306.00
4
(1)

A synthetic serine protease inhibitor that could lead to increased PRSS39 activity by competitive inhibition of other proteases, thereby redirecting substrates.

Camostat mesylate

59721-29-8sc-203867
sc-203867A
sc-203867B
sc-203867C
sc-203867D
sc-203867E
10 mg
50 mg
500 mg
1 g
10 g
100 g
$43.00
$183.00
$312.00
$624.00
$2081.00
$4474.00
5
(0)

A protease inhibitor that could upregulate PRSS39 through compensatory cellular mechanisms when other proteases are inhibited.

Tranexamic acid

1197-18-8sc-204921
sc-204921A
5 g
10 g
$29.00
$50.00
10
(1)

An antifibrinolytic that could increase PRSS39 activity indirectly due to the broad modulation of the protease-antiprotease balance.

Leupeptin hemisulfate

103476-89-7sc-295358
sc-295358A
sc-295358D
sc-295358E
sc-295358B
sc-295358C
5 mg
25 mg
50 mg
100 mg
500 mg
10 mg
$73.00
$148.00
$316.00
$499.00
$1427.00
$101.00
19
(3)

A thiol protease inhibitor that, through inhibitory feedback, could lead to upregulation or activation of serine proteases including PRSS39.

Aprotinin

9087-70-1sc-3595
sc-3595A
sc-3595B
10 mg
100 mg
1 g
$112.00
$408.00
$3000.00
51
(2)

A polypeptide inhibitor of several serine proteases that could cause an increase in PRSS39 activity by feedback regulation mechanisms.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$281.00
$947.00
$1574.00
14
(0)

An irreversible cysteine protease inhibitor that may indirectly upregulate serine proteases such as PRSS39 as part of a broader cellular response.